Status:
COMPLETED
Dexmedetomidine in Thoracoscopic Surgery: Opioid-Sparing Strategy
Lead Sponsor:
Kaohsiung Veterans General Hospital.
Conditions:
Opioid Use
Postoperative Pain
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Numerous studies in recent years have shown that the use of opioid-free analgesia can reduce opioid use and length of stay in the recovery room, as published in the journals Anesthesia \& Analgesia1. ...
Detailed Description
Study protocol All patients received target-controlled infusion (TCI) propofol (3-5 μg ml-1), 2% lidocaine 1.5 mg kg-1 and cisatracurium (0.15-0.2 mg kg-1) or rocuronium (0.6-1.0 mg kg-1). During in...
Eligibility Criteria
Inclusion
- Age older than 20 years old and younger than 75 years old
- Diagnosed as stage I-III non-small cell lung cancer
- Received video-assisted thoracoscopic lung wedge resection or lobectomy
Exclusion
- Cardiac arrhythmia , such as sinus bradycardia, sinus tachycardia, or high-degree atrioventricular block
- Diagnosed acute myocardial myocardial infarction, congestive heart failure, or stroke within one year
- Patient have underwent coronary artery bypass graft
- Allergy to drug such as Propofol, Sevoflurane, Dexmedetomidine, NSAID, Lidocaine)
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT05431322
Start Date
June 1 2022
End Date
October 31 2023
Last Update
January 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan